Skin manifestations of suspected COVID-19: Complications of the disease or reactivation of latent viral infections?

Mariko Sugawara-Mikami; Norihisa Ishii; Masashi Yamazaki; Takeshi Kambara; Hiroaki Sasaki; Natsuo Tachikawa; Rie Yotsu

doi:10.1016/j.jdcr.2021.03.032

Skin manifestations of suspected COVID-19: Complications of the disease or reactivation of latent viral infections?

JAAD Case Rep. 2021 Jun:12:15-17. doi: 10.1016/j.jdcr.2021.03.032. Epub 2021 Mar 26.

Authors

Mariko Sugawara-Mikami^{1

2

3

4}, Norihisa Ishii⁵, Masashi Yamazaki⁵, Takeshi Kambara⁶, Hiroaki Sasaki⁷, Natsuo Tachikawa⁷, Rie Yotsu^{8

9

10}

Affiliations

¹ West Yokohama Sugawara Dermatology Clinic, Kanagawa, Japan.
² Department of Dermatology, Tokyo Women's Medical University, Tokyo, Japan.
³ Department of Clinical Laboratory Science, Faculty of Medical Technology, Teikyo University, Tokyo, Japan.
⁴ Department of Dermatology, Yokohama City University, Kanagawa, Japan.
⁵ National Sanatorium Tama Zenshoen, Tokyo, Japan.
⁶ Department of Dermatology, Yokohama Municipal Citizen's Hospital, Kanagawa, Japan.
⁷ Department of Infectious Diseases, Yokohama Municipal Citizen's Hospital, Kanagawa, Japan.
⁸ Department of Tropical Medicine, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
⁹ School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
¹⁰ Department of Dermatology, National Center for Global Health and Medicine, Tokyo, Japan.

No abstract available

Keywords: CMV; CMV, cytomegalovirus; COVID-19; EBV; EBV, Epstein-Barr virus; RT-PCR; RT-PCR, reverse-transcriptase polymerase chain reaction; SARS-CoV-2; antibody; co-infection; false-negative; latent viral infection; skin manifestations.

Publication types

Case Reports